FDA News
FDA Approves Lysteda to Treat Heavy Menstrual Bleeding
The U.S. Food and Drug Administration today approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). Lysteda works by stabilizing a protein that helps blood to clot.
- 16 reads
- Feed: Fda News Releases
- Original article
IDS Sports Conducts a Voluntary Nationwide Recall of Bromodrol, Dual Action Grow Tabs, Grow Tabs, Mass Tabs, and Ripped Tabs TR
IDS Sports announced today that it is
conducting a voluntary nationwide recall of five of the company’s dietary supplement products sold
under the following names: Bromodrol, Dual Action Grow Tabs, Grow Tabs, Mass Tabs, and
Ripped Tabs TR.
The Food And Drug Administration (FDA) has notified IDS Sports that the recalled products contain the
following undeclared substances, which FDA considers to be
- Read more
- 16 reads
- Feed: FDA Recalls
- Original article
Conagra Foods Issues Nationwide Allergy Alert on a Limited Number of 15 oz. Tubs of Blue Bonnet Light Spread
Today, ConAgra Foods, in cooperation with the U.S. Food and Drug Administration (FDA) is voluntarily recalling a limited number of 15 oz. tubs of Blue Bonnet Spread that were inadvertently mispackaged—the lid is for regular Blue Bonnet Spread and the tub portion describes the product as Blue Bonnet Light Spread. The product inside of the tub is regular Blue Bonnet Spread.
- Read more
- 18 reads
- Feed: FDA Recalls
- Original article
FDA Statement on Vibrio Vulnificus in Raw Oysters
Several weeks ago, the FDA announced its intent to change, by summer 2011, its policy regarding the post-harvest processing of raw Gulf Coast oysters harvested in the warmer months.
Local Anesthetics, Continuously Infused (marketed as bupivacaine, chlorprocaine, lidocaine, mepivacaine, procaine, ropivacaine) - Chondrolysis
Reports of chondrolysis in patients given continuous intra-articular infusions of local anesthetics with elastomeric infusion devices.
- 24 reads
- Feed: Medwatch News
- Original article
FDA Clears First Rapid Test for Bacterial Contamination in Pooled Platelets
The U.S. Food and Drug Administration today cleared for marketing the Platelet PGD Test System, the first rapid test for the detection of bacterial contamination in pooled platelets derived from whole blood.
- 24 reads
- Feed: Fda News Releases
- Original article
Genzyme Products, Marketed as Cerezyme, Fabrayzme, Myozyme, Aldurazyme, and Thyrogen
Foreign particle contamination of several products manufactured by Genzyme, which may lead to serious adverse events including damage to blood vessels or embolic events, and anaphylactic, allergic and immune-mediated reactions.
- 24 reads
- Feed: Medwatch News
- Original article
GMP Herbal Products, Inc. Issues a Voluntary Nationwide Recall of a Weight Loss Supplement Found to Contain Undeclared Drug Ingredients
Herbal Products, Inc. has been informed by the Food and Drug Administration (FDA) that Pai You Guo, a weight loss dietary supplement, sold and marketed by the firm contains undeclared drug ingredients.
- Read more
- 21 reads
- Feed: FDA Recalls
- Original article
FDA To Look Into Safety of Caffeinated Alcoholic Beverages
The Food and Drug Administration today notified nearly 30 manufacturers of caffeinated alcoholic beverages that it intends to look into the safety and legality of their products.
FDA Takes Action against Seafood Processing Company, Executives
The U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration, has filed a complaint for permanent injunction against seafood processor Haifa Smoked Fish Inc. of Jamaica, N.Y., and two of its top officers for violations of the Federal Food, Drug and Cosmetic Act.
